Across its top 20 institutional holders, BAX's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 8/100, avg. turnover score 18/100).

Quarterly Activity

Recent Activity

+$4.2B

Total Buy Value

$5.7B

Total Sell Value

New buy70

Trim264

Add192

Sold out122

262

Net Buyers

386

Net Sellers

Game Theory Scenarios

Bearish— Distribution Signal

Institutional distribution signals bearish outlook for BAX

Signal Basis

13F data for the quarter ending 2026-03-31 shows net institutional outflow of approximately $844 million, with 386 net sellers versus 262 net buyers, and 122 exits compared to 70 new buys, indicating broad-based selling.

Confirmation

Sustained institutional divestment in upcoming quarters or any emerging insider selling would reinforce the bearish thesis.

Invalidation Risk

A reversal in institutional flows (net accumulation) or a notable insider buying campaign could invalidate this bearish view.

The scenarios above are AI-generated directly from institutional holders' Form 13F filings on SEC EDGAR and describe historical patterns only. Not investment advice — see the underlying institutional filings linked below.

See the institutional 13F filings behind this signal

Smart Money Convergence

BAX does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.

13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/BAX

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

Filings (14d)

Data as of 2026-07-14

2026-07-14

Baxter International Inc. is consolidating its reporting segments from three to two, effective in the second quarter of 2026. The new structure combines the former Pharmaceuticals business into the Medical Products & Therapies (MPT) segment, alongside the standalone Healthcare Systems & Technologies (HST) segment. To maintain comparability, Baxter filed recast historical financial data matching the new structure.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

CUSIP

071813109, 71813109

FAQ

Who are the top institutional investors holding BAXTER INTERNATIONAL INC (BAX)?

Major stakeholders currently include BlackRock, Inc. ($1.3B), Pzena Investment Management LLC ($1.1B), Dodge & Cox ($961.9M). Based on the latest 13F filings, there are a total of 664 tracked investment funds and institutions maintaining positions in BAX.

What is the overall institutional sentiment toward BAX recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $844.1M, driven by 262 managers accumulating shares while 386 reduced their exposure.

Which institutions have been selling or reducing their BAX positions?

In the latest period, 264 funds trimmed their holdings, and 122 managers completely exited their positions. The aggregate reported sell value was $5.7B.

Are there any notable investors adding BAX to their portfolios?

Yes, buying activity remains notable. 70 institutions opened new positions in {ticker}, and 192 existing holders added to their shares. The total reported buy value for the quarter amounted to $4.2B.

Related Stocks

Same Sector

Other stocks in the same GICS sector

JNJ

Johnson & Johnson

Institutions Holding

4,605

Total reported value

$438.9B

616 institutions currently hold both BAX and this stock

View detail

LLY

Eli Lilly & Co

Institutions Holding

4,338

Total reported value

$730.5B

605 institutions currently hold both BAX and this stock

View detail

ABBV

Abbvie INC

Institutions Holding

4,029

Total reported value

$283.9B

602 institutions currently hold both BAX and this stock

View detail

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,153

Total reported value

$2.1T

3246 13F institutions increased their position this quarter

View detail

AMZN

Amazon.com INC

Institutions Holding

5,960

Total reported value

$1.5T

3030 13F institutions increased their position this quarter

View detail

NVDA

Nvidia CORP

Institutions Holding

5,769

Total reported value

$3.0T

2744 13F institutions increased their position this quarter

View detail

Developer Access

Access BAX's institutional ownership data programmatically:

REST API

curl https://alphasmo.com/api/v1/market/stock/BAX

CLI

npx alphasmo stocks get BAX

Full API & MCP documentation →